Registry of Lobbyists

Monthly Communication Report

2182-382339

Registrant name: ANDRE ALBINATI
Client: Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration: 775866-2182-23
Communication date: 2016-07-29
Posted date: 2016-08-15

Designated Public Office Holders who participated in the communication: Robert Asselin, Director of Policy
Finance Canada (FIN)
 
Subject Matter of the communication: International Trade
 

Date Modified: